Many heart attack patients not referred to cardiac rehab

| September 7, 2009

By Steven Reinberg, HealthDay Reporter MONDAY, July 27 (HealthDay News) — Even though cardiac rehabilitation has been shown to guard against future heart trouble once a cardiovascular event has landed someone in the hospital, only 56 percent of these patients are referred for the therapy, a new study finds. Despite national guidelines that say hospitalized […]

Cardiac rehabilitation saves lives

| September 7, 2009

June 8th, 2009 Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the […]

Cardiac Biomarker Levels Strongly Predict Outcome Of Bypass Surgery

| September 7, 2009

ScienceDaily (Sep. 6, 2009) — Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found. Their report implies that, while […]

Drug Eluting Stents – Should Hospitals be Concerned?

| September 6, 2009

September 6, 2009 by Haroon Rashid1) “Drug Eluting Stents may carry a greater risk of thrombosis than their bare metal counterparts, according to research presented at the 2006 World Congress of Cardiology (WCC)”! 2). “Recent studies increase concern among researchers about potential for dangerous blood clots in individuals with drug eluting stents, what does this […]

Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina.

| September 4, 2009

Campbell AR, Satran D, Zenovich AG, Campbell KM, Espel JC, Arndt TL, Poulose AK, Boisjolie CR, Juusola K, Bart BA, Henry TD. Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN 55407, USA. BACKGROUND: Enhanced external counterpulsation (EECP) is a noninvasive treatment of patients with refractory angina. The immediate hemodynamic effects of EECP are […]

Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement

| September 1, 2009

WESTBURY, N.Y.–(BUSINESS WIRE)–Vasomedical, Inc. (“Vasomedical”) (OTC: VASO – News), a world leader in the noninvasive treatment of cardiovascular diseases, today announced that evidence presented by Dr. Eva-Elina Buschmann on behalf of the European Arteriogenesis Network 2 Trial, at the 2009 European Society of Cardiology (ESC) Congress taking place in Barcelona, Spain, demonstrates that EECP® therapy […]

Prophylactic Coronary Angiography in Medium- to High-Risk Patients Undergoing Major Vascular Surgery

| August 31, 2009

Writer: Dharam J. Kumbhani, M.D., S.M. Description Two recent trials, CARP and DECREASE-V, noted that routine coronary artery revascularization before vascular surgery is not associated with improved outcomes. Accordingly, current American College of Cardiology/American Heart Association guidelines recommend noninvasive testing for patients undergoing vascular surgery, only if two or more risk factors, as assessed by Lee’s […]

Breaking report confirms exercise better than angioplasty for stable coronary disease–Can it be true?

| August 31, 2009

In stable coronary artery disease (CAD), analysis has shown a 27% reduction of total mortality from exercise, compared to more aggressive intervention. At least four mechanisms are at play: better endothelial (coronary artery inner lining) function, reduced rate of coronary deposits, reduced clotting risk, and improved new arterial growth. When compared to balloon angioplasty with […]


| August 27, 2009

In the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) trial, EECP improved exercise duration, symptom status, and QOL in patients with mild-to-moderate heart failure who were already receiving optimal medical therapy. The PEECH trial, reported at the 2005 ACC meeting by Arthur M. Feldman, MD, PhD, FACC, enrolled 187 patients with ischemic or […]

In NEJM Editorial, UB Cardiologist Recommends Optimal Medical Therapy, CABG, over PCI in Diabetics with Heart Disease

| August 12, 2009

William E. Boden has written an editorial in the New England Journal of Medicine that urges caution about new research on diabetics with coronary disease. Release Date: June 7, 2009 BUFFALO, N.Y. — In an editorial in the current issue of the New England Journal of Medicine (NEJM), William E. Boden, M.D., professor of medicine […]